000 03998naa a22005297i 4500
001 UMUN-OA-20261005-PH-054
003 local
005 20261005174916.0
006 m o d
007 cr||||||||||||
008 261005s2014 xx o u000 0 eng d
024 7 _a10.1289/ehp.1307893
_2doi
035 _a(local)EuropePMC:PMC4181929
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aPaula I Johnson
_eauthor.
245 1 4 _aThe Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. /
_cPaula I Johnson; Patrice Sutton; Dylan S Atchley [and others].
264 1 _a[Place of publication not identified] :
_bAmerican Chemical Society,
_c2014.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aBackground The Navigation Guide methodology was developed to meet the need for a robust method of systematic and transparent research synthesis in environmental health science. We conducted a case study systematic review to support proof of concept of the method. Objective We applied the Navigation Guide systematic review methodology to determine whether developmental exposure to perfluorooctanoic acid (PFOA) affects fetal growth in humans. Methods We applied the first 3 steps of the Navigation Guide methodology to human epidemiological data: 1) specify the study question, 2) select the evidence, and 3) rate the quality and strength of the evidence. We developed a protocol, conducted a comprehensive search of the literature, and identified relevant studies using prespecified criteria. We evaluated each study for risk of bias and conducted meta-analyses on a subset of studies. We rated quality and strength of the entire body of human evidence. Results We identified 18 human studies that met our inclusion criteria, and 9 of these were combined through meta-analysis. Through meta-analysis, we estimated that a 1-ng/mL increase in serum or plasma PFOA was associated with a -18.9 g (95% CI: -29.8, -7.9) difference in birth weight. We concluded that the risk of bias across studies was low, and we assigned a "moderate" quality rating to the overall body of human evidence. Conclusion On the basis of this first application of the Navigation Guide systematic review methodology, we concluded that there is "sufficient" human evidence that developmental exposure to PFOA reduces fetal growth.
540 _aCC0 public-domain dedication. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/publicdomain/mark/1.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Public Health.
653 _aB. Sc. Public Health
653 _aUMUN open access collection
653 _aenvironmental health
655 4 _aReview articles.
700 0 _aPatrice Sutton
_eauthor.
700 0 _aDylan S Atchley
_eauthor.
700 0 _aErica Koustas
_eauthor.
700 0 _aJuleen Lam
_eauthor.
700 0 _aSaunak Sen
_eauthor.
700 0 _aKaren A Robinson
_eauthor.
700 0 _aDaniel A Axelrad
_eauthor.
700 0 _aTracey J Woodruff
_eauthor.
773 0 _tEnvironmental health perspectives
_gVol. 122, no. 10, (2014), pages/article 1028-1039
_x0091-6765
856 4 0 _uhttps://europepmc.org/articles/PMC4181929
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC4181929
_qlocal
942 _n0
999 _c1326
_d1326